Alarming rate of 30-day hospital readmissions in patients with liver cirrhosis.
作者信息
Ebhohon Ebehiwele, Ogundipe Olumuyiwa Akinbolaji, Adejumo Adeyinka Charles
机构信息
Department of Internal Medicine, Lincoln Medical Center, Bronx, NY, USA.
Applied Clinical Research Program, St. Cloud State University Minnesota, St. Cloud, MN, USA.
出版信息
Ann Transl Med. 2021 Nov;9(21):1608. doi: 10.21037/atm-21-5258.
Abstract
摘要
相似文献
1
Alarming rate of 30-day hospital readmissions in patients with liver cirrhosis.肝硬化患者30天内再入院率惊人。
Ann Transl Med. 2021 Nov;9(21):1608. doi: 10.21037/atm-21-5258.
2
Same- vs Different-Hospital Readmissions in Patients With Cirrhosis After Hospital Discharge.肝硬化患者出院后在同一家医院和不同医院的再入院情况比较。
Am J Gastroenterol. 2019 Mar;114(3):464-471. doi: 10.14309/ajg.0000000000000050.
3
Incidence and predictors of 30-day hospital readmissions for liver cirrhosis: insights from the United States National Readmissions Database.肝硬化患者30天内再次入院的发生率及预测因素：来自美国国家再入院数据库的见解
Ann Transl Med. 2021 Jul;9(13):1052. doi: 10.21037/atm-20-1762.
4
Cirrhosis as a Comorbidity in Conditions Subject to the Hospital Readmissions Reduction Program.肝硬化作为医院再入院减少计划相关疾病的一种合并症。
Am J Gastroenterol. 2019 Sep;114(9):1488-1495. doi: 10.14309/ajg.0000000000000257.
5
Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.加利福尼亚州肝硬化患者的医院肝硬化容量和再入院情况。
Dig Dis Sci. 2018 Sep;63(9):2267-2274. doi: 10.1007/s10620-018-4964-0. Epub 2018 Feb 19.
6
Risk Factors for 30-Day Readmissions of Individuals with Decompensated Cirrhosis.失代偿期肝硬化患者30天再入院的危险因素
South Med J. 2015 Nov;108(11):682-7. doi: 10.14423/SMJ.0000000000000371.
7
Hospital readmissions among patients with decompensated cirrhosis.失代偿期肝硬化患者的住院再入院率。
Am J Gastroenterol. 2012 Feb;107(2):247-52. doi: 10.1038/ajg.2011.314. Epub 2011 Sep 20.
8
The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis.在北美一个大型肝硬化患者队列中，3个月再入院率仍然高得令人无法接受。
Hepatology. 2016 Jul;64(1):200-8. doi: 10.1002/hep.28414. Epub 2016 Feb 19.
9
Rate, reasons, predictors, and burden of readmissions after transjugular intrahepatic portosystemic shunt placement.经颈静脉肝内门体分流术（TIPS）后再入院率、再入院原因、预测因素和负担。
J Gastroenterol Hepatol. 2021 Mar;36(3):775-781. doi: 10.1111/jgh.15194. Epub 2020 Sep 8.
10
A Quality Improvement Initiative Reduces 30-Day Rate of Readmission for Patients With Cirrhosis.一项质量改进举措降低了肝硬化患者的30天再入院率。
Clin Gastroenterol Hepatol. 2016 May;14(5):753-9. doi: 10.1016/j.cgh.2015.08.041. Epub 2015 Sep 25.
引用本文的文献
1
Hepatic encephalopathy and spontaneous bacterial peritonitis are associated with increased liver-related readmissions in cirrhosis.肝性脑病和自发性细菌性腹膜炎与肝硬化患者肝脏相关再入院率增加有关。
Front Med (Lausanne). 2025 Jan 31;12:1417222. doi: 10.3389/fmed.2025.1417222. eCollection 2025.
本文引用的文献
1
Incidence and predictors of 30-day hospital readmissions for liver cirrhosis: insights from the United States National Readmissions Database.肝硬化患者30天内再次入院的发生率及预测因素：来自美国国家再入院数据库的见解
Ann Transl Med. 2021 Jul;9(13):1052. doi: 10.21037/atm-20-1762.
2
Assessment of Potentially Preventable Hospital Readmissions After Major Surgery and Association With Public vs Private Health Insurance and Comorbidities.主要手术后潜在可预防的再次住院评估及与公共与私人医疗保险和合并症的关系。
JAMA Netw Open. 2021 Apr 1;4(4):e215503. doi: 10.1001/jamanetworkopen.2021.5503.
3
Moving Toward Impact: An Introduction to Implementation Science for Gastroenterologists and Hepatologists.迈向影响力：胃肠病学家和肝病学家实施科学导论
Gastroenterology. 2020 Dec;159(6):2007-2012. doi: 10.1053/j.gastro.2020.07.063. Epub 2020 Sep 18.
4
Lower household income is associated with an increased risk of hospital readmission in patients with decompensated cirrhosis.家庭收入较低与失代偿性肝硬化患者的住院再入院风险增加相关。
J Gastroenterol Hepatol. 2021 Apr;36(4):1088-1094. doi: 10.1111/jgh.15153. Epub 2020 Jul 14.
5
Readmissions Among Patients Admitted With Acute Decompensated Heart Failure Based on Income Quartiles.按收入四分位数分组的急性失代偿性心力衰竭患者再入院情况。
Mayo Clin Proc. 2019 Oct;94(10):1939-1950. doi: 10.1016/j.mayocp.2019.05.027.
6
Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study.酒精性肝炎的再入院率及相关结局：一项全国性队列研究
Dig Dis Sci. 2020 Apr;65(4):990-1002. doi: 10.1007/s10620-019-05759-4. Epub 2019 Aug 1.
7
HEPACONTROL. A program that reduces early readmissions, mortality at 60 days, and healthcare costs in decompensated cirrhosis.HEPACONTROL. 一种可降低失代偿期肝硬化患者早期再入院率、60 天死亡率和医疗成本的方案。
Dig Liver Dis. 2018 Jan;50(1):76-83. doi: 10.1016/j.dld.2017.08.024. Epub 2017 Aug 13.
8
Sepsis at a Safety Net Hospital: Risk Factors Associated With 30-Day Readmission.安全网医院中的脓毒症：与 30 天再入院相关的危险因素。
J Intensive Care Med. 2019 Nov-Dec;34(11-12):1017-1022. doi: 10.1177/0885066617726753. Epub 2017 Aug 18.
9
Strategies to Reduce 30-Day Readmissions in Patients with Cirrhosis.降低肝硬化患者30天再入院率的策略。
Curr Gastroenterol Rep. 2017 Jan;19(1):1. doi: 10.1007/s11894-017-0543-3.
10
Early outpatient follow-up and 30-day outcomes in patients hospitalized with cirrhosis.肝硬化住院患者的早期门诊随访和 30 天结局。
Hepatology. 2016 Aug;64(2):569-81. doi: 10.1002/hep.28558. Epub 2016 Apr 28.
Zotero 插件